Radiofrequency ablation in the management of liver metastases from breast cancer.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 17885061.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Systemic chemotherapy remains the standard treatment for patients with breast cancer hepatic metastases. Resection of metastases has survival advantages in a small percentage of selected patients. Radiofrequency ablation has been used in small numbers of selected patients. This small series was undertaken to review our experience with radiofrequency ablation in the management of patients with breast cancer hepatic metastases. Radiofrequency ablation of breast cancer hepatic metastases is safe and may be used to control hepatic deposits in patients with stable or no extrahepatic disease.
Medical subject headings
- Breast Neoplasms
- Catheter Ablation
- Liver Neoplasms
- Neoplasm Recurrence, Local